DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Chemotherapy Induced Nausea & Vomiting (CINV) Market" report to their offering.
The report provides and in-depth analysis of the global CINV market and respective drugs. The report gives an insight of the global CINV market by 5-HT3 and NK-1 drug receptor antagonists.
The report also includes analysis of the North American CINV market. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CINV market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Global CINV market has increased at a significant CAGR during the years 2013-2015 and projections are made that the market would rise tremendously in the next four years i.e. 2016-2020. The CINV market is expected to increase due to growth in global cancer incidence, increasing health expenditure and the increasing outbreak of factors working towards causing cancer. Yet, the market faces some challenges such as discontinuation of chemotherapy treatment, several unmet medical needs, no drugs for the HEC regimen in the delayed CINV, etc.
- Heron Therapeutics, Inc.
- Merck & Co., Inc.
- Novartis AG
Key Topics Covered:
1. Executive Summary
3. Global Market Analysis
4. Regional Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profile
For more information about this report visit http://www.researchandmarkets.com/research/6fmj5l/global